Locke FL, Oluwole OO, Kuruvilla J, Thieblemont C, et al. Axicabtagene ciloleucel versus standard of care in second-line large B-cell lymphoma: outcomes by metabolic tumor volume. Blood 2024 Apr 1:blood.2023021620. doi: 10.1182/blood.2023021620.
PMID: 38557775